Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Tumor Marker Control | Fujirebio
differences between HE4, CA125, and ROMA values and sensitivity, PPV,... | Download Scientific Diagram
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer - Gynecologic Oncology
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting - Gynecologic Oncology
PLOS ONE: Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer
Preoperative HE4 levels and characteristics of patients with epithelial... | Download Table
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Reference ranges of HE4 and CA125 according to age group | Download Table
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text
Serum CA125, HE4 and ROMA levels according to histology, FIGO stage and... | Download Table
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
Table 2 from Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
![PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb4db523eb74d476a02524b225eb0835b20657d2/7-Table4-1.png "PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar")
PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
Which Tumor Marker Can Be Used to Assess Stage, Prognosis, Response to Treatment? | ONS Voice
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
HE4 reference range in healthy populations according to age or... | Download Table
Tumor marker (composed of CA125 and HE4) after surgery, during... | Download Scientific Diagram
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports
Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses - American Journal of Obstetrics & Gynecology
